Status:

NOT_YET_RECRUITING

TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE

Lead Sponsor:

University of Sao Paulo General Hospital

Collaborating Sponsors:

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conditions:

Sjogren Syndrome

Sjogren Disease

Eligibility:

FEMALE

30-65 years

Phase:

PHASE4

Brief Summary

Sjögren's disease (SjD) is a chronic, immune-mediated, systemic inflammatory disease characterized mainly by involvement of the salivary and lacrimal glands, causing symptoms of sicca syndrome. The di...

Detailed Description

This is a prospective randomized study lasting 6 months. Sixty SjD patients (pre- or post-menopausal) and with complaints of vaginal dryness will be included and randomized into two groups: 30 patient...

Eligibility Criteria

Inclusion

  • Diagnosis of SjD according to the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria (2016).
  • Controlled systemic disease activity \[EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)\] \< 5 and without use of glucocorticoids or with a maximum dose of prednisone of 15 mg/day.
  • Present complaints of vaginal dryness upon study entry.
  • Agreeing to participate in the protocol according to the informed consent form signed before study inclusion.

Exclusion

  • History of breast, uterine or ovarian neoplasia, history of thromboembolic events, heart, kidney or liver failure.
  • Other associated autoimmune rheumatic diseases, such as spondyloarthritis, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, dermatomyositis and mixed connective tissue disease.
  • Conditions that may mimic SjD, such as history of head and neck radiation therapy, acquired immunodeficiency syndrome, hepatitis B and C, sarcoidosis, IgG4-related disease, and graft-versus-host disease.

Key Trial Info

Start Date :

January 19 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2029

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT07153276

Start Date

January 19 2026

End Date

December 30 2029

Last Update

October 3 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.